A new multiple anti-infective non surgical therapy in the treatment of peri-implantitis: a case series.
Minerva Stomatol. 2017 Oct 03;:
Authors: Mensi M, Scotti E, Calza S, Pilloni A, Grusovin MG, Mongardini C
Abstract
BACKGROUND: Peri-implantitis is a frequent disease that may lead to implant loss. The aim of this case series was to evaluate the clinical results of a new non-surgical treatment protocol.
METHODS: Fifteen patients with dental implants affected by peri-implantitis were treated with a multiple anti-infective non-surgical treatment (MAINST) which included two steps: 1) supra-gingival decontamination of the lesion and sub-gingival treatment with a controlled-release topical doxycycline; 2) after one week, a session of supra and sub gingival air polishing with Erythritol powder and ultrasonic debridement (where calculus was present) of the whole oral cavity was performed along with a second application of topical doxycycline around the infected implant. Primary outcome measures were: implant failure; complications and adverse events; recurrence of peri-implantitis; secondary outcome measure were presence of Plaque (PI), Bleeding on Probing (BOP), Probing Pocket Depth (PPD). Recession (REC), Relative Attachment level (RAL).
RESULTS: Neither implant failure nor complications nor adverse events were reported. Statistically (p < 0.01) and clinically significant reductions between baseline and 1 year of PI (100% vs 13.9%, CI95% 72.4%; 93.7%); BOP (98.5% vs 4.5%, CI95% 85.4%; 98.5%) and PPD (7.89mm vs 3.16mm CI95% -5.67; -3.77), were detected. At baseline, all 15 patients had a PPD > 5 mm at the affected implant(s), whereas only 3.7% at 3 month follow-up a PPD> 5 mm, and none at 6 and 12 months.
CONCLUSIONS: Within the limits of this study, the MAINST protocol showed improvement of clinical parameters for the treatment of peri-implantitis, which were maintained for up to 12 months.
PMID: 28975771 [PubMed - as supplied by publisher]
from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/2fTCgzu
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου